Literature DB >> 26318358

Preoperative predictors and outcomes of right ventricular assist device implantation after continuous-flow left ventricular assist device implantation.

Nikhil Prakash Patil1, Prashant N Mohite2, Anton Sabashnikov2, Dhruva Dhar3, Alexander Weymann2, Mohamed Zeriouh2, Rachel Hards2, Michael Hedger2, Fabio De Robertis2, Toufan Bahrami2, Mohamed Amrani2, Shelley Rahman-Haley4, Nicholas R Banner3, Aron Frederik Popov2, André Rüdiger Simon2.   

Abstract

OBJECTIVE: The outcomes of ventricular assist device therapy remain limited by right ventricular failure. We sought to define the predictors and evaluate the outcomes of right ventricular failure requiring right ventricular assist device support after long-term continuous-flow left ventricular assist device implantation.
METHODS: Records of all continuous-flow left ventricular assist device recipients for the last 10 years were analyzed, including patients on preoperative intra-aortic balloon pump, extracorporeal membrane oxygenation, and short-term ventricular assist device support. Perioperative clinical, echocardiographic, hemodynamic, and laboratory data of continuous-flow left ventricular assist device recipients requiring right ventricular assist device support (right ventricular assist device group) were compared with the rest of the patient cohort (control group).
RESULTS: Between July 2003 and June 2013, 152 patients underwent continuous-flow left ventricular assist device implantation as a bridge to transplantation. The overall postoperative incidence of right ventricular assist device support was 23.02% (n = 35). Right ventricular assist device implantation did not significantly affect eventual transplantation (P = .784) or longer-term survival (P = .870). Preoperative right ventricular diameter (P < .001), tricuspid annular plane systolic excursion (P < .001), previous sternotomy (P = .002), preoperative short-term mechanical support (P = .005), left atrial diameter (P = .014), female gender (P = .020), age (P = .027), and preoperative bilirubin levels (P = .031) were univariate predictors of right ventricular assist device implantation. Multivariate analysis revealed lesser tricuspid annular plane systolic excursion (P = .013; odds ratio, 0.613; 95% confidence interval, 0.417-0.901) and smaller left atrial diameter (P = .007; odds ratio, 0.818; 95% confidence interval, 0.707-0.947) as independent predictors of right ventricular assist device implantation. Receiver operating characteristic curve of tricuspid annular plane systolic excursion yielded an area under the curve of 0.85 (95% confidence interval, 0.781-0.923), with cutoff tricuspid annular plane systolic excursion less than 12.5 mm having 84% sensitivity and 75% specificity.
CONCLUSIONS: Lesser tricuspid annular plane systolic excursion and smaller left atrial diameter are independent predictors of the need for right ventricular assist device support after continuous-flow left ventricular assist device implantation. Right ventricular assist device implantation does not adversely affect eventual transplantation or survival after continuous-flow left ventricular assist device implantation.
Copyright © 2015 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  bridge to transplant; left ventricular assist device; right ventricular assist device; right ventricular failure

Mesh:

Year:  2015        PMID: 26318358     DOI: 10.1016/j.jtcvs.2015.07.090

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  7 in total

Review 1.  Echocardiographic assessment for ventricular assist device placement.

Authors:  Antolin S Flores; Michael Essandoh; Gregory C Yerington; Amar M Bhatt; Manoj H Iyer; William Perez; Victor R Davila; Ravi S Tripathi; Katja Turner; Galina Dimitrova; Michael J Andritsos
Journal:  J Thorac Dis       Date:  2015-12       Impact factor: 2.895

2.  Temporary assist device support for the right ventricle: pre-implant and post-implant challenges.

Authors:  Michael Dandel; Roland Hetzer
Journal:  Heart Fail Rev       Date:  2018-03       Impact factor: 4.214

3.  Causes and predictors of early mortality in patients treated with left ventricular assist device implantation in the European Registry of Mechanical Circulatory Support (EUROMACS).

Authors:  Sakir Akin; Osama Soliman; Theo M M H de By; Rahatullah Muslem; Jan G P Tijssen; Felix Schoenrath; Bart Meyns; Jan F Gummert; Paul Mohacsi; Kadir Caliskan
Journal:  Intensive Care Med       Date:  2020-02-03       Impact factor: 17.440

4.  2019 EACTS Expert Consensus on long-term mechanical circulatory support.

Authors:  Evgenij V Potapov; Christiaan Antonides; Maria G Crespo-Leiro; Alain Combes; Gloria Färber; Margaret M Hannan; Marian Kukucka; Nicolaas de Jonge; Antonio Loforte; Lars H Lund; Paul Mohacsi; Michiel Morshuis; Ivan Netuka; Mustafa Özbaran; Federico Pappalardo; Anna Mara Scandroglio; Martin Schweiger; Steven Tsui; Daniel Zimpfer; Finn Gustafsson
Journal:  Eur J Cardiothorac Surg       Date:  2019-08-01       Impact factor: 4.191

Review 5.  Temporary Right-Ventricular Assist Devices: A Systematic Review.

Authors:  Mahmoud Abdelshafy; Kadir Caliskan; Goksel Guven; Ahmed Elkoumy; Hagar Elsherbini; Hesham Elzomor; Erhan Tenekecioglu; Sakir Akin; Osama Soliman
Journal:  J Clin Med       Date:  2022-01-26       Impact factor: 4.241

6.  Prediction of right ventricular failure after left ventricular assist device implantation in patients with heart failure: a meta-analysis comparing echocardiographic parameters.

Authors:  Louis-Emmanuel Chriqui; Pierre Monney; Matthias Kirsch; Piergiorgio Tozzi
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-10-29

Review 7.  Concurrent Left Ventricular Assist Device (LVAD) Implantation and Percutaneous Temporary RVAD Support via CardiacAssist Protek-Duo TandemHeart to Preempt Right Heart Failure.

Authors:  Bastian Schmack; Alexander Weymann; Aron-Frederik Popov; Nikhil Prakash Patil; Anton Sabashnikov; Jamila Kremer; Mina Farag; Andreas Brcic; Christoph Lichtenstern; Matthias Karck; Arjang Ruhparwar
Journal:  Med Sci Monit Basic Res       Date:  2016-05-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.